Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trilogy International Partners Inc T.TRL.WT.A


Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.


TSXV:TRL.H - Post by User

Comment by eSnowdenon Nov 13, 2015 8:43am
175 Views
Post# 24288252

RE:RE:RE:RE:RE:No Worries here...

RE:RE:RE:RE:RE:No Worries here...If you bought the shares a few years ago, then you must be seriously underwater with this investment. You will be lucky to break even. Negativity comes with the price action of the stock, if the price was at a more reasonable level; you would hear zero complaints from me.

I bring up usefulness of the technology that Acerus relies on; a nasal delivery--a delivery that requires 3x daily dosages. That is a double whammy. FIrst you have a delivery mechanism that the mult-billion dollar pharma won't touch, and secondly, it takes 3 dosages to get the proper amount of active ingredient into the bloodstream, whereas other transdermal meds require 2 dosages. So, not only the delivery tech is unaccepted by the larger community, the tech itself is sub-standard.

Now put that in your pipe and smoke it.




Bullboard Posts